The synthesis of a new series of 2-(aryl)alkylthio derivatives of N-ethylcarboxamido adenosine (NECA) is described, in comparison with the corresponding derivatives of adenosine. Binding studies (A 1 , A 2A , and A 3 ) and adenylyl cyclase activity (A 2B ) at human adenosine receptor subtypes stably transfected in Chinese hamster ovary (CHO) cells showed that the 2-(aryl)alkylthioadenosine derivatives are more potent than the corresponding NECA derivatives at A 1 receptors, while the NECA derivatives possess highest affinity at both A 2A and A 3 receptors. Thus, the 2-(1-pentyl)thioadenosine (7) with a K i A 1 = 91 nM, the 2-phenylethylthioNECA (18) with a K i A 2A = 24 nM, and the 2-phenylmethylthioadenosine (11) with a K i A 3 = 68 nM, could be useful tools to be modificated in order to find very potent and selective agonists for the human adenosine receptor subtypes.
Introduction
Adenosine (Ado, 1) is a naturally-occurring nucleoside which is reported to modulate a variety of physiological and pathophysiological processes through the interaction with at least for subtypes of a family of cell-surface G-protein-coupled receptors. [1] [2] [3] These four adenosine receptors (ARs), named A 1 , A 2A , A 2B , and A 3 , have widespread tissue distribution and are often co-expressed in the same cell type. 
Figure 1
A series of 2-amino, 2-alkoxy, 2-alkythio-, 2-alkynyl-, and 2-alkenyl-derivatives of adenosine and N-ethylcarboxamidoadenosine (NECA, 2) 6 have been synthesized and tested mainly on different models of rat A 1 and A 2A receptor subtypes. From these studies some ligands, such as CGS 21680 (3), 2-(1-hexyn-1-yl)-5'-N-ethylcarboxamidoadenosine (HENECA, 4), and 2-(3-hydroxy-3-phenyl-1-propyn-1-yl)-5'-N-ethylcarboxamidoadenosine (PHPNECA, 5), showed to possess high A 2A affinity combined, in some cases, with good A 2A vs A 1 selectivity. More detailed characterization of these ligands at the four cloned human adenosine receptor subtypes revealed that none of the prototypical adenosine receptor agonists exhibits at the same time high affinity and selectivity for the human A 2A AR subtype. Both NECA and CGS 21680, which are available as radioligands for this subtype, have lower affinity at human than at rat receptor. The 2-alkynylNECA derivatives HENECA and PHPNECA showed high affinity also at human A 3 receptors. In particular, (S)-PHPNECA displayed K i s in the low nanomolar range at A 1 , A 2A , and A 3 subtypes and an EC 50 of 200 nM at human A 2B receptor.
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Further structure-activity relationship studies, carried out often only at A 1 and A 2A receptor subtypes, had anyhow defined important features of the recognition sites for ARs agonists. The iodoNECA (14) 14-16 with the appropriate mercaptans in dry DMF at 120 °C using potassium carbonate as a catalyst (Scheme 1 and Table 1 ). The receptor-stimulated adenylyl cyclase activity expressed as EC 50 , nM. NECA (2), CGS 21680 (3), HENECA (4), and PHPNECA (5) were reported as reference compounds and the results are shown in Table 2 . 17 The reference compound NECA (2) showed high affinity at A 1 , A 2A , and A 3 receptors and was slightly A 3 selective (K i A 1 = 14 nM, K i A 2A = 20 nM, and K i A 3 = 6.2 nM). The potency for A 2B receptor, in the low micromolar range, characterized NECA as one of the most active nucleoside at this subtype (EC 50 A 2B = 2,400 nM).
The introduction of a 4-(2-carboxyethyl)phenylethylamino group in 2-position of NECA resulted in a compound, CGS 21680 (3), which showed decreased affinity and potency at A 1 , A 3 , and A 2B adenosine receptor subtypes, while its affinity at the The 2-(aryl)alkylthio derivatives of adenosine and NECA (compounds 7-13 and 15-19, respectively) showed affinity at A 1 , A 2A , and A 3 adenosine receptor subtypes ranging from low nM to low µM value. On the contrary, functional data demonstrated that they did not activate the A 2B receptors; in fact all the compounds possessed an EC 50 A 2B > 100 µM.
Surprisingly, many compounds (7, 8, 10, 13, 19) showed slight selectivity for the A 1 receptor, a subtype that is known to be activated preferentially by N 6 -substituted adenosine derivatives; the most potent was the 2-(1-pentyl)thioadenosine (7) with a K i A 1 = 91 nM. The affinity of the corresponding NECA derivatives 15 decreased at all adenosine receptor subtypes, but these data are to be evaluated with caution because of problems of compound solubility. Substitution of the methyl of the 2-alkylthio chain in compound 7 with an hydroxyl group (compound 8) decreased affinity at all receptors. It is worthwhile to note that only three compounds (9, 12, 18) bound selectively the A 2A receptor subtype; thus, both in adenosine and in NECA series, the presence in 2-position of a phenylethylthio substituent was useful in order to improve A 2A affinity. In fact, the 2-phenylethylthioadenosine (12) and the 2-phenylethylthioNECA (18) were the most active A 2A agonists with a K i A 2A = 85 nM and 24 nM, respectively. Once again, as in the case of CGS 21680, the presence of a particular substituent in the 2-position of NECA led to a compound which showed decreased affinity and potency at both A 1 , A 3 , and A 2B adenosine receptor subtypes, while maintaining a A 2A affinity comparable to that of NECA, hence resulting in A 2A selectivity.
On the other hand, the presence of a longer chain (phenylpropylthio) led to two derivatives, compounds 13 and 19, which activated preferentially the A 1 receptors, while a shorter chain is better accommodated by the A 3 receptor subtype; in fact the 2-phenylmethylthioadenosine (11) and the 2-phenylmethylthioNECA (17) were A 3 selective and compounds 11 was the most active A 3 agonist among the two series with a K i A 3 = 68 nM.
On the contrary, when the phenyl ring is directly linked to the sulfur atom the corresponding adenosine and NECA derivatives (compounds 10 and 16, respectively) showed a different profile of activity; thus the 2-phenylthioadenosine was slightly A 1 selective, while the corresponding NECA derivatives 16 was A 3 selective. In conclusion, although the preference for the different adenosine receptor subtypes seems do not clearly depend on the nature of the substituent present in the two position, in all cases the 2-(aryl)alkylthioadenosine derivatives are more potent than the corresponding NECA derivatives at A 1 receptors, 19 while the NECA derivatives possess higher affinity in comparison with adenosines at both A 2A and A 3 receptors, with the exception of compound 17 which is less active than the corresponding adenosine derivative 11 at A 3 receptor subtypes.
Conclusions
Biological data obtained with the two series of adenosine and NECA derivatives demonstrated that it is possible to modulate the activity at the A 1 , A 2A , and A 3 adenosine receptor subtypes by introducing different (aryl)alkylthio substituents in the 2-position of adenosine and NECA. In fact the best compounds emerging from this study, 2-(1-pentyl)thioadenosine (7) with a K i A 1 = 91 nM, 2-phenylethylthioNECA (18) with a K i A 2A = 24 nM, and the 2-phenylmethylthioadenosine (11) with a K i A 3 = 68 nM, could be useful tools to be modificated in order to find very potent and selective agonists for the human adenosine receptor subtypes. 1 The procedure was performed as described previously. Due to the lack of a suitable radioligand the relative potency of agonists at A 2B adenosine receptors was determined in adenylyl cyclase experiments. The procedure was carried out as described previously with minor modifications. 20 
